Delivery Order SPE2DR25D7066-SPE2DR26F7ZPG
- Not listed
- The Defense Logistics Agency awarded a $1,694.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 29, 2025, with completion targeted for September 2, 2025. This non-set-aside delivery order represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $19,727.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 15, 2025, with completion scheduled for December 16, 2025. This non-competitive delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $6,679.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), represents a competitively awarded, non-set-aside procurement with an ultimate completion date of December 8, 2025. The product will be performed at...
- The Defense Logistics Agency awarded a $3,339.50 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by December 8, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $5,700.57 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on November 13, 2025, with completion scheduled for November 14, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a $4,936.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of September 2, 2025. This is an unset-aside, competitively awarded contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $21,713.92 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 16, 2025, with an ultimate completion date of December 17, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes, valued at $18,401.20 with a firm fixed price structure. This non-set-aside competitive award is set for completion by December 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $8,876.48 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, and performance is scheduled for completion by December 4, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,526.96 firm fixed price delivery order on November 17, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. The contract, which is non-set-aside and competitively awarded, is set to complete by November 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DR25D7066Indefinite Delivery Contract
- SPE2DR25D7066-SPE2DR26F7ZPGDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $9,217.02 firm fixed-price delivery order on December 22, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes to be delivered to Conshohocken, Pennsylvania, with completion scheduled for December 23, 2025. This is a non-set-aside, competitively awarded contract issued as a child order under AmerisourceBergen's larger contract vehicle with DLA. The delivery order represents a routine pharmaceutical supply transaction consistent with AmerisourceBergen's role as a critical federal medical procurement vendor. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key supplier within the DLA's Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 12/21/25 |